相关实验视频

Updated: Jun 22, 2025

Chemotherapy-induced Vascular Toxicity - Real-time In vivo Imaging of Vessel Impairment

Chemotherapy-induced Vascular Toxicity - Real-time In vivo Imaging of Vessel Impairment

Published on: January 7, 2015

血管正常化对放射治疗敏感性的潜力

Zhili Guo^1,2,3, Lingling Lei^1,2, Zenan Zhang^1,2,3

¹Key Laboratory of Medical Imaging Precision Theranostics and Radiation Protection, College of Hunan Province, The Affiliated Changsha Central Hospital, Hengyang Medical School, University of South China, Changsha, China.

|July 2, 2024

概括

放射疗法是一种放射治疗.

科学领域:

在瘤学瘤学.
辐射瘤学辐射瘤学
癌症生物学癌症生物学

背景情况:

放射治疗通过电离辐射的DNA损伤诱导癌细胞亡.
恶性瘤微环境 (TME),以缺氧,低pH值和高间歇性压力为特征,减弱了放射治疗的疗效.
异常的瘤血管结构有助于有害的TME,削弱了传统放射治疗的结果.

研究的目的:

审查放射治疗敏感化和血管正常化方面的研究进展.
探索调节血管正常化的策略,以提高放射治疗的疗效.
讨论血管正常化的应用前景,以改善放射治疗敏感度.

主要方法:

关于放射治疗机制和瘤微环境的文献综述.
分析瘤血管化和放射治疗反应之间的关系.
对癌症治疗中血管正常化的当前策略的综合.

主要成果:

缺氧性TME和异常的瘤新血管系统显著降低了放射治疗的有效性.
瘤血管的正常化可以改善TME,从而提高放射治疗的疗效.
调节血管正常化为放射治疗敏感化提供了一个有希望的策略.

结论:

通过血管正常化改善瘤微环境对于增强放射治疗至关重要.
向瘤血管提供了一种可行的方法来克服放射治疗耐药性.
对血管正常化策略的进一步研究具有优化癌症放射治疗的巨大潜力.

关键词:

物理治疗是一种物理治疗.辐射敏感化辐射敏感化放射疗法是一种放射治疗.瘤微环境是一个微环境.血管正常化的正常化.

更多相关视频

Assessment of Vascular Regeneration in the CNS Using the Mouse Retina

Assessment of Vascular Regeneration in the CNS Using the Mouse Retina

Published on: June 23, 2014

Reduction of Radiation Exposure during Endovascular Treatment of Peripheral Arterial Disease Combining Fiber Optic RealShape Technology and Intravascular Ultrasound

Reduction of Radiation Exposure during Endovascular Treatment of Peripheral Arterial Disease Combining Fiber Optic RealShape Technology and Intravascular Ultrasound

Published on: April 21, 2023

相关概念视频

Regulation of Angiogenesis and Blood Supply

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...